Disc Medicine

Yahoo Finance • last month

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma cash and cash equival... Full story

Yahoo Finance • last month

Cantor Fitzgerald reiterates Overweight rating on Disc Medicine stock

Investing.com - Cantor Fitzgerald maintained its Overweight rating and $132.00 price target on Disc Medicine (NASDAQ:IRON) on Wednesday. The company, currently trading at $58.18 with a market capitalization of $2 billion, has seen its stoc... Full story

Yahoo Finance • last month

Bitterman Kevin, director at Disc Medicine, sells $1.96m in iron stock

Director Kevin Bitterman of Disc Medicine, Inc. (NASDAQ:IRON) sold a total of 32,174 shares of common stock on August 13 and 14, 2025. The sales, executed under a prearranged Rule 10b5-1 trading plan, totaled $1.96 million. The biotech com... Full story

Yahoo Finance • 2 months ago

Disc medicine CFO Franchi sells $119k in shares

Jean M. Franchi, Chief Financial Officer of Disc Medicine, Inc. (NASDAQ:IRON), sold 2,031 shares of common stock on July 17, 2025, at a price of $59.00, totaling $119,829. The transaction occurred near the stock’s current trading price of... Full story

Yahoo Finance • 3 months ago

Commodity Roundup: Gold rises as tariff worries lift safe-haven demand ahead of key inflation data

[gold bars on brown background] Sanlad/iStock via Getty Images Gold prices (XAUUSD:CUR [https://seekingalpha.com/symbol/XAUUSD:CUR]) edged higher on Tuesday as concerns over the impact of US tariffs boosted the metal’s safe-haven appeal,... Full story

Yahoo Finance • 3 months ago

Disc Medicine CEO Quisel sells $286k in shares

Disc Medicine, Inc. (NASDAQ:IRON) Chief Executive Officer John D Quisel, sold 5,200 shares of common stock on July 3, 2025, at prices ranging from $55.00 to $55.26, for a total value of $286,454. The transaction occurred with the stock tra... Full story

Yahoo Finance • 3 months ago

Vietnam slaps anti-dumping tariffs on hot-rolled steel imports from China

[Iron pipe centrifugal pipe casting machine at the foundry] Vladimir Zapletin/iStock via Getty Images Vietnam’s Ministry of Industry and Trade has imposed five-year anti-dumping duties on certain hot-rolled steel imports from China, effec... Full story

Yahoo Finance • 3 months ago

H.C. Wainwright reaffirms Buy rating on Disc Medicine stock at $118 target

Investing.com - H.C. Wainwright has reiterated its Buy rating and $118.00 price target on Disc Medicine (NASDAQ:IRON), maintaining its positive outlook on the biopharmaceutical company. Currently trading at $53.17, the stock has shown stro... Full story

Yahoo Finance • 4 months ago

Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress

Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase 1b study of DISC-09... Full story

Yahoo Finance • 4 months ago

Disc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from... Full story

Yahoo Finance • 7 months ago

Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Targeting NDA submission for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 through accelerated approval pathway; on track to initiate APOLLO post-marketing confirmatory trial by mid-2025Positive update from Phase 1b trial of... Full story

Yahoo Finance • 8 months ago

Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

WATERTOWN, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffe... Full story

Yahoo Finance • 8 months ago

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

WATERTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffe... Full story

Yahoo Finance • 8 months ago

Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission

Pursuing accelerated approval for bitopertin in EPP with protoporphyrin IX (PPIX) reduction as the surrogate endpoint Planning to submit NDA under accelerated approval pathway in H2 2025 based on existing clinical data, including results f... Full story

Yahoo Finance • 8 months ago

Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

WATERTOWN, Mass., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering fro... Full story

Yahoo Finance • 8 months ago

Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)

WATERTOWN, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering fro... Full story

Yahoo Finance • 2 years ago

Analysts on Wall Street Lower Ratings for These 10 Stocks

In this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts on Wall Street Lower Ratings for These 5 Stocks. European financial markets e... Full story

Yahoo Finance • 2 years ago

Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin

WATERTOWN, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering fro... Full story

Yahoo Finance • 2 years ago

Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update

Completed enrollment of BEACON and AURORA trials of bitopertin in erythropoietic protoporphyria (EPP); BEACON expanded to include adolescentsData from all adult patients in BEACON to be presented in an oral presentation at the 65th America... Full story

Yahoo Finance • 2 years ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates

Completion of enrollment for phase 2 BEACON and AURORA studies of bitopertin in erythropoietic protoporphyria (EPP)Oral presentation at ASH meeting of updated interim data from BEACON, including a preliminary analysis of the precedented pi... Full story